Etiologic factors of dyspnea at the end of life;Factores etiológicos de la disnea al final de la vida

Medicina Paliativa

Volumn 15, Issue 3, 2008, Pages 143-148

  Cuervo Pinna, Miguel Ángel ^a,c   Mota Vargas, R ^a   Redondo Moralo, M J ^a   Sanchez Correas M A ^a   Pera, G ^b  

^a Equipo de Cuidados Paliativos de Badajoz   (Spain)

^b Statistician Unitat de Suport A la Recerca Àmbit Barcelonè Nord i Maresme   (Spain)

^c NONE   (Spain)

Author keywords

Dyspnea; Etiology factor; Terminal disease

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DYSPNEA; FEMALE; HEALTH PROGRAM; HEART DISEASE; HOME; HOSPITAL PATIENT; HUMAN; KARNOFSKY PERFORMANCE STATUS; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OXYGEN SATURATION; PALLIATIVE THERAPY; POPULATION RESEARCH; STATISTICAL ANALYSIS; TERMINAL DISEASE;

EID: 47549112186     PISSN: 1134248X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Reuben DB, Mor V. Dyspnea in terminally ill cancer patients. Chest 1986 (89): 234-6.
2. rd ed. New York: Oxford 2005. p. 587-618.
3. Bruera E, Schmitz B, Pither J, Newman CM, Hanson J. The frecuency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000; (21): 373-9.
4. Redondo Moralo MJ, Cuervo Pinna MA. Síntomas respiratorios en Cuidados Paliativos. Aten Primaria 2006; 38 (Supl. 1): 38-46.
5. st ed. Great Britain: Oxford 2006. p. 655-62.
6. Heyse Moore LH, Ross V, Mullee MA. How much of a problem is dyspnea in advanced cancer? Pall Med 1991; (5): 20-6.
7. Bruera E, Scmitz B, Pither J, Neumann C, Hanson J. The frecuency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000; (5): 357-62.
8. Conill C, Verger E, Henríquez I, Saiz N, Espier M, Lugo F, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage 1997; (14): 328-31.
9. Muers MF, Roun CE. Palliation of symptoms in non-small cell lung cancer: A study by the Yorkshire Regional Cancer Organisation thoracic group. Thorax 1993; (48): 339-43.
10. Mercadante S, Casiccio A, Fulfaro F. The course of symptom frequency and intensity in advanced cancer patients followed at home. J Pain Symptom Manage 2000; (20): 104-12.
11. Porcel JM. Tratamiento paliativo del derrame pleural maligno. Med Pal 2003 (10): 142-8.
12. Dudgeon D, Kristjanson L, Sloan J, Lertzman M, Clement K. Dyspnea in cancer patients: Prevalence and associated factors. J Pain Symptom Manage 2001 (21): 95-102.
13. a ed. Nueva York: Oxford University Press; 2006. p. 205-36.
14. Booth S, Nelly M, Cox N, Adams L, Guz A. Does oxigen help dyspnoea in patients with cancer? Am J Respir Crit Care Med 1996; (153): 1515-8.
15. Bruera E, Stoutz N, Velasco-Leiva A, Scholler T, Hanson J. Effect of oxygen on dyspnoea in hypoxemic terminal cancer patients. Lancet 1993; 342: 13-4.
16. Philip J, Gold M, Milner A, Di Julio J, Miller B, Spruit O. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manage 2006; (32): 541-50.
17. Bruera E, Scmitz B, Pither J, Neumann C, Hanson J. The frecuency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000; (5): 357-62.
18. Dudgeon D, Lertzman M. Dyspnea in the advanced cancer patient. J Pain Symptom Manage 1998; (16): 212-9.
19. Gleeson C, Spencer D. Blood transfusion and its benefits in palliative care. Pall Med 1996; (9): 307-13.
20. Monti M, Castellani L, Berlusconi A, Cunietti E. Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit. J Pain Symptom Manage 1996; (12): 18-22.
21. st ed. New York: Oxford; 2003. p. 177-89.